Gal-9 co-expression with PD-L1 and their co-localization in some GBM cases serve as further evidence for the link between TIM-3/Gal-9 and PD-1/PD-L1 pathways as supported by published data (118). The gene discussed is HAVCR2; the disease is glioblastoma.